Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ANL

Adlai Nortye (ANL)

Adlai Nortye Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANL
DateTimeSourceHeadlineSymbolCompany
08/08/20247:30AMGlobeNewswire Inc.Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational ProgressNASDAQ:ANLAdlai Nortye Ltd
08/08/20247:00AMGlobeNewswire Inc.Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of DirectorsNASDAQ:ANLAdlai Nortye Ltd
05/23/20248:03PMGlobeNewswire Inc.Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024NASDAQ:ANLAdlai Nortye Ltd
05/22/20247:00AMGlobeNewswire Inc.Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation TherapyNASDAQ:ANLAdlai Nortye Ltd
05/13/20243:29PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANLAdlai Nortye Ltd
03/29/20245:00AMGlobeNewswire Inc.Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & DevelopmentNASDAQ:ANLAdlai Nortye Ltd
11/17/20236:30AMGlobeNewswire Inc.Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCCNASDAQ:ANLAdlai Nortye Ltd
10/23/20237:12AMGlobeNewswire Inc.Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster AwardNASDAQ:ANLAdlai Nortye Ltd
10/03/202311:05AMGlobeNewswire Inc.Adlai Nortye Ltd. Announces Closing of Initial Public OfferingNASDAQ:ANLAdlai Nortye Ltd
09/29/20231:46AMGlobeNewswire Inc.Adlai Nortye Ltd. Announces Pricing of Initial Public OfferingNASDAQ:ANLAdlai Nortye Ltd
 Showing the most relevant articles for your search:NASDAQ:ANL